OrthoSensor, Inc.
- Industry
- Medical Devices
- Founded Year
- 2006
- Headquarters
- 1855 Griffin Road, Suite A-310, Dania Beach, FL 33004, United States
- Employee Count
- 87
Key People
- Ivan Delevic - Chief Executive Officer
- Roman Bensen - Chief Financial Officer
- Martin Roche - Founder & Chief Medical Officer
- Jonathan Trousdale - Chief Technology Officer
- Steve Seger - Chief Commercial Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with significant backgrounds in medical technology and business management.
The presence of multiple successful MedTech entrepreneurs in the leadership team suggests a strong foundation for strategic decision-making and industry insight.
- Clinical Need
-
Aspect: Very Strong
Summary: OrthoSensor addresses a critical need for real-time data in orthopedic surgeries to improve patient outcomes.
By providing surgeons with real-time data, OrthoSensor's devices enhance surgical precision and patient recovery, meeting a pressing clinical demand.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The orthopedic device market is highly competitive with numerous established players.
The presence of numerous competitors, including large strategic companies, makes it difficult for new entrants to gain significant market share.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of sensor-assisted orthopedic devices involves manageable technical challenges.
The technology required for sensor integration in orthopedic devices is established, allowing for predictable development pathways.
- Patent
-
Aspect: Strong
Summary: OrthoSensor holds a robust portfolio of patents protecting its technologies.
A solid patent portfolio safeguards the company's innovations, deterring competitors and supporting market exclusivity.
- Financing
-
Aspect: Strategics
Summary: The acquisition by Stryker provides substantial financial backing and resources.
Integration into a larger corporation like Stryker offers access to extensive resources, facilitating product development and market expansion.
- Regulatory
-
Aspect: 510k/PMA + Reimbursement
Summary: OrthoSensor's products have obtained necessary regulatory approvals and reimbursement pathways.
Achieving 510(k) and PMA approvals, along with established reimbursement, facilitates product acceptance and commercial success.
Opportunity Rollup
- Odds of Success
- 3
- Peak Market Share
- 3.3
- Segment CAGR
- 3.0%
- Market Segment
- Orthopedic Devices
- Market Sub Segment
- Sensor-Assisted Total Knee Arthroplasty
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.16 |
| 2 | 0.49 |
| 3 | 1.15 |
| 4 | 2.31 |
| 5 | 3.30 |
Key Takeaway
OrthoSensor, now part of Stryker, is well-positioned to leverage its innovative sensor-assisted orthopedic technologies in a growing market, supported by strong leadership and financial backing.